June 26, 2021 - The NASH Podcast - Surfing the NASH Tsunami Podcast

S2-E34 – #ILC2021 Day Three – Multi-Disciplinary NAFLD Thinking, with Exciting Drugs on the Horizon

Manal Abdelmalek, Ian Rowe and first-timer Ken Cusi join Louise Campbell and Roger Green to review a thought-provoking, assumption-challenging Day Three of #ILC2021.

June 26, 2021

Day: June 26, 2021

All Podcast Categories

S2-E34 – #ILC2021 Day Three – Multi-Disciplinary NAFLD Thinking, with Exciting Drugs on the Horizon

Discussion Group

Join The Discussion in our LinkedIn or Facebook Discussion Groups

Join The Live Recordings

Recording for this session will take place at 3:15p Eastern US time (1900H CET, 1800H BT) on Monday.

Join The Discussion…

NASH & Diabetes Podcast and NASH Tsunami Podcast

S3-E1.2 – NAFLD Prevalence and Type 2 Diabetes in an Endocrinology Clinic: The Need for Screening and Vigilance

S3-E1.1 – Fatty Liver Prevalence May Be Higher Than Previously Thought, Especially Among Type 2 Diabetes Patients

S1-E1 – New Podcast: Growing NAFLD-Diabetes Dual Prevalence Increases CVD Risk for Diabetics

S3-E1.2 – NAFLD Prevalence and Type 2 Diabetes in an Endocrinology Clinic: The Need for Screening and Vigilance

S3-E33 – Day 4 of ILC2022: Friendly debates about NITs and the Patient Advocate’s Perspective

S3-E32 – Days 1 — 3 of ILC 2022: The Value of FIB-4 and In-Person Meetings

S3-E1.1 – Fatty Liver Prevalence May Be Higher Than Previously Thought, Especially Among Type 2 Diabetes Patients

S3-E30.4 – Highlighting Intriguing ILC2022 Abstracts: Potential Uses of FIB-4

S3-E30.3 – Highlighting Intriguing ILC2022 Abstracts: More on NAFLD Quality of Life

S3-E30.2 – Highlighting Intriguing ILC2022 Abstracts: Elastography and the Importance of NAFLD Quality-of-Life Metrics

S3-E30.1 – Highlighting Intriguing ILC2022 Abstracts: Machine Learning Identified NASH Biomarkers and a Cost-Effectiveness Study

S3-E30 – Previewing #ILC2022: Focus on NITs and Patients

S3-E29.2 – #NASHDay 2022 Wrap-Up Panel: The Importance of #StopNASHNow